An antibody defense against COVID-19: One of the responses of the immune system to invading viruses is the production of antibodies. Some of these are neutralizing, meaning that they prevent the virus from being infectious, and can thus be used to treat viral diseases. Wu et al. isolated four neutralizing antibodies from a convalescent coronavirus disease 2019 (COVID-19) patient. Two of the antibodies, B38 and H4, blocked the receptor binding domain (RBD) of the viral spike protein from binding to the cellular receptor, angiotensin-converting enzyme 2 (ACE2). The structure of the RBD bound to B38 shows that the B38-binding site overlaps with the binding site for ACE2. Although H4 also blocks RBD binding to ACE2, it binds at a different site, and thus the two antibodies can bind simultaneously. This pair of antibodies could potentially be used together in clinical applications. Science , this issue p. 1274
1 December 2014 in Research in Astronomy and Astrophysics
As the dynamic evolution of SARS-CoV-2 led to reduced efficacy in monoclonal neutralizing antibodies and emergence of immune escape, the role of bispecific antibodies becomes crucial in bolstering antiviral activity and suppressing immune evasion. This review extensively assesses a spectrum of representative bispecific antibodies targeting SARS-CoV-2, delving into their characteristics, design formats, mechanisms of action, and associated advantages and limitations. The analysis encompasses factors influencing the selection of parental antibodies and strategies for incorporating added benefits in bispecific antibody design. Furthermore, how different classes of parental antibodies contribute to augmenting the broad-spectrum neutralization capability within bispecific antibodies is discussed. In summary, this review presents analyses and discussions aimed at offering valuable insights for shaping future strategies in bispecific antibody design to effectively confront the challenges posed by SARS-CoV-2 and propel advancements in antiviral therapeutic development.
Machine learning algorithms have become the key components in many big data applications. However, the full potential of machine learning is still far from been realized because using machine learning algorithms is hard, especially on distributed platforms such as Hadoop and Spark. The key barriers come from not only the implementation of the algorithms themselves, but also the processing for applying them to real applications which often involve multiple steps and different algorithms. In this demo we present a general-purpose dataflow-based system for easing the process of applying machine learning algorithms to real world tasks. In the system, a learning task is formulated as a directed acyclic graph (DAG) in which each node represents an operation (e.g., a machine learning algorithm), and each edge represents the flow of the data from one node to its descendants. Graphical user interface is implemented for making users to create, configure, submit, and monitor a task in a drag-and-drop manner. Advantages of the system include 1) lowering the barriers of defining and executing machine learning tasks; 2) sharing and re-using the implementations of the algorithms, the task dataflow DAGs, and the (intermediate) experimental results; 3) seamlessly integrating the stand-alone algorithms as well as the distributed algorithms in one task. The system has been deployed as a machine learning service and can be access from the Internet.